clinical trials of immune checkpoint inhibitors in acute myeloid leukemia (aml)
Published 7 years ago • 200 plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
7:32
current immune checkpoint inhibitor trials in aml/mds
-
3:21
nox2: a potential immune checkpoint for inhibition in aml
-
5:42
immune checkpoint inhibitors in mds and aml
-
1:51
checkpoint inhibition in the treatment of mpns
-
4:55
checkpoint inhibitor combination approaches for aml/mds: an update
-
4:59
checkpoint inhibitors in aml
-
6:44
checkpoint inhibitor advances in aml
-
2:01
predict response to immune checkpoint inhibition in acute myeloid leukemia (aml) using biomarkers
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
2:43
t-cell engaging treatment in aml
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
2:11
beat aml master trial: novel precision medicine approach in aml
-
5:20
immuno-oncology agents for mm: checkpoint inhibitors and nk-cells
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
2:22
session highlights: idh inhibitors, salvage regimens, and other novel developments in aml
-
5:35
clinical and prognostic significance of aberrant t-cell marker expression in aml
-
1:48
the challenges of choosing the right target antigen in aml compared to all
-
1:09
pre-measure: patients with aml in complete remission but high risk of relapse following allohct